Get a Sample
Schedule a Meeting
Get a Sample
Table Of Content
April 2025
The global vacuum blood collection tube market size is calculated at USD 3.16 billion in 2025 and is forecasted to reach around USD 4.22 billion by 2034, accelerating at a CAGR of 3.27% from 2025 to 2034. The North America market size surpassed USD 1.10 billion in 2024 and is expanding at a CAGR of 3.42% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The global vacuum blood collection tube market size accounted for USD 3.06 billion in 2024 and is predicted to increase from USD 3.16 billion in 2025 to approximately USD 4.22 billion by 2034, expanding at a CAGR of 3.27% from 2025 to 2034. The vacuum blood collection tube market is growing due to rising demand for accurate diagnostics, increased prevalence of chronic diseases, and advancements in healthcare infrastructure.
Artificial Intelligence is revolutionizing blood medicine supply by enabling real-time tracking of blood samples using barcodes or smart labels. AI also aids in selecting the correct tube type and blood quantity for each test. In busy labs, AI streamlines tube handling, saving time and identifying unusual test results to alert staff. This early monitoring enhances patient management by ensuring reliable results, making vacuum blood collection faster, safer, and more productive, ultimately leading to better outcomes for patients and healthcare professionals. Furthermore, AI helps track blood collection volumes, flags potential errors in testing, and provides more accurate results, potentially leading to advancements in tube design, materials, and manufacturing, thereby enhancing diagnostic accuracy and safety.
The U.S. vacuum blood collection tube market size was exhibited at USD 771.12 million in 2024 and is projected to be worth around USD 1,085.91 million by 2034, growing at a CAGR of 3.48% from 2025 to 2034.
Why Did North America Lead the Vacuum Blood Collection Tube Market?
North America led the global market while holding a 36% in 2024. This is mainly due to the presence of leading manufacturers of medical devices, including vacuum blood collection tube. Major manufacturers and suppliers have established significant businesses in the region, streamlining distribution, innovation, and product availability. The increased prevalence of chronic diseases like diabetes, cardiovascular diseases, and cancer is driving the need for frequent blood testing, necessitating the development of effective and safe blood collection systems. Government support and funding for healthcare services, along with regulatory schemes, ensure the use of quality and compliant medical products in hospitals and labs.
The U.S. dominates the North American vacuum blood collection tube market. The increased prevalence of chronic diseases, which require regular diagnostic tests, has led to a rise in the use of vacuum blood collection tubes in hospitals, clinics, and labs. There is a strong focus on patient-centered care in the U.S., which futlrther boosts the adoption of new, non-invasive blood sample collection techniques.
Why is Asia Pacific Witnessing the Fastest Growth in the Vacuum Blood Collection Tube Market?
Asia Pacific is expected to grow at the fastest CAGR during the forecast period. The prevalence of chronic and lifestyle-related diseases is increasing in the region. An aging population in countries like China and India are leading to a rise in chronic disease prevalence, which are diagnosed and monitored through blood tests. The increasing prevalence of diabetes is driving the demand for glucose monitoring and, consequently, vacuum blood collection tubes. The rising need for effective, accurate, and safe blood collection devices in hospitals, clinics, and diagnostic labs further contributes to regional market growth.
China significantly contributes to the growth of the Asia Pacific vacuum blood collection tube market. Government efforts to improve healthcare infrastructure and primary diagnosis are increasing the demand for diagnostic equipment, including vacuum blood collection tubes. The Chinese government’s focus on improving diagnostics and population health is encouraging manufacturers to invest in this area.
What are the Major Factors Driving the Growth of the Europe Vacuum Blood Collection Tube Market?
The market within Europe is expected to grow at a notable rate. The growth of diagnostic labs and hospital facilities, along with the integration of automated laboratory systems, is boosting the need for effective blood collection solutions. This has led to the introduction of vacuum blood collection tubes as a crucial part of maintaining sample integrity and improving the reliability of diagnostic procedures. The trend toward preventive healthcare and early disease screening in Europe is also leading to more routine check-ups and screenings that rely heavily on blood testing.
The UK is a major player in the European market, largely due to the increase in cancer cases. The trend toward personalized medicine and precision oncology in the UK also increases the need for advanced blood collection technologies. Government projects and budgets allocated to developing cancer diagnostics and reducing waiting times further increase the use of vacuum blood collection tubes in the UK.
The vacuum blood collection tube market refers to the global industry involved in the production and distribution of sterile, vacuum-sealed tubes used to collect, transport, and store blood samples for diagnostic, therapeutic, and research purposes. These tubes are pre-evacuated to draw a specific volume of blood directly from a vein into the container during venipuncture. They are widely used in hospitals, diagnostic laboratories, outpatient centers, and blood banks for various tests, including hematology, biochemistry, serology, and molecular diagnostics. The market is driven by increased diagnostic testing, rising disease burden, technological advancements in blood collection devices, and the growing need for safe and efficient blood collection systems.
The vacuum blood collection tube market is experiencing significant growth, driven by the rising prevalence of chronic and infectious diseases, including diabetes and cardiovascular conditions. These diseases necessitate frequent blood tests for diagnosis and monitoring of patient health, thereby increasing the demand for safe and accurate blood collection methods. Furthermore, the global increase in blood transfusions and surgical procedures is also contributing to the market’s expansion.
| Report Coverage | Details |
| Market Size by 2034 | USD 4.22 Billion |
| Market Size in 2025 | USD 3.16 Billion |
| Market Size in 2024 | USD 3.06 Billion |
| Market Growth Rate from 2025 to 2034 | CAGR of 3.27% |
| Dominating Region | North America |
| Fastest Growing Region | Asia Pacific |
| Base Year | 2024 |
| Forecast Period | 2025 to 2034 |
| Segments Covered | Product Type, Material, Application, End User, Distribution Channel, and Region |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Strong Emphasis on Early Detection
With the increased burden of diseases like diabetes, heart problems, cancer, and autoimmune conditions, there is a strong emphasis on early disease detection. Moreover, the rise of infectious diseases like HIV, hepatitis, tuberculosis, and COVID-19 has increased the demand for precise and rapid diagnostic tests. Routine blood testing is crucial for assessing patient responses to treatment and disease progression. As more people require regular and reliable diagnostic testing, healthcare systems are adopting innovative blood collection strategies to ensure quality and reduce contamination risks. Government and healthcare initiatives promoting preventive checkups and screenings have further increased the demand for safe and effective blood sampling equipment.
Supply Chain Issues
The major factor hindering the growth of the global vacuum blood collection tube market is the supply chain vulnerability of raw materials, particularly polyethylene. Polyethylene, a plastic used in manufacturing blood collection tubes, is closely linked to the global oil market. Fluctuations in crude oil prices impact the cost and supply of polyethylene, making production unpredictable. Material shortages can arise from geopolitical tensions, trade restrictions, transportation delays, or natural disasters, disrupting the supply chain. These factors force manufacturers to adjust prices frequently, destabilizing the industry and affecting operational efficiency.
Product Customization for Personalized Medicine
The rise of personalized medicine presents a significant opportunity in the global vacuum blood collection tube market. As healthcare shifts toward customized diagnostics and therapies, specialized blood collection procedures have become more important. Companies like Becton Dickinson are leading the way by developing blood collection tubes tailored for specific genetic testing or biomarker analysis. These innovations are crucial for detecting gene mutations and cancer markers, which are essential for targeted therapies.
Why Did the Serum Tubes Segment Dominate the Vaccum Blood Collection Tube in 2024?
The serum tubes segment dominated the market while holding the largest share in 2024. This is mainly due the widespread use of serum tubes in various biochemical and serological tests. These tubes are favored in clinical labs because they provide high-quality serum samples with minimal interference. The rise in chronic diseases like heart disease, diabetes, and cancer created the need for diagnostic procedures, thus increasing the demand for serum separator tubes (SSTs). Technological advancements have also improved their efficiency, sample integrity, and shelf life. The growth of personalized medicine is driving the need for more individualized diagnostic products, prompting manufacturers to develop SSTs tailored to specific regional needs in biomarker and genetic testing.
The plasma separation tubes segment is expected to grow at a significant CAGR over the forecast period. These tubes are designed to separate plasma from whole blood using a gel or additive barrier after centrifugation, allowing for quick and uncontaminated extraction. The growing need for accurate, efficient, and cost-effective blood analysis, especially in infectious disease testing, hormone tests, and drug level detection, is driving medical facilities to use plasma separation tubes. These tubes ensure high-quality samples and reduce the risk of hemolysis, simplifying lab work.
How Does the Plastic Segment Dominate the Market in 2024?
The plastic segment dominated the vaccum blood collection tube market with a 88% revenue share in 2024 and is expected to sustain its position during the forecast period. This is because of the increased use of polyethylene terephthalate (PET) as the material of choice in the manufacturing process. PET tubes are strong, lightweight, break-resistant, and safer than glass. Their high chemical resistance ensures that blood samples remain stable and uncontaminated during transport and storage, crucial for accurate testing. The increasing automation in labs also favors PET, as these plastic tubes are easily handled by high-throughput systems and robots.
The glass segment is expected to grow at a notable rate in the upcoming period. Glass is ideal for sensitive assays needing a stable environment because it doesn’t interact with blood or additives. Its resistance to gas permeability and clarity make it useful in biochemical and serological tests. Manufacturers are also working on making glass tubes stronger and less fragile.
What Made Routine Chemistry the Dominant Segment in the Market in 2024?
The routine chemistry segment dominated the vaccum blood collection tube market, capturing a 28% share in 2024. This is mainly due to the increased burden of chronic diseases like hypertension, diabetes, heart disease, and cancers. These diseases require routine blood testing to get insights into diseases progression and manage conditions. The growing awareness of preventive care and more routine checkups are boosting the demand for blood testing services globally. Developing countries are also expanding their healthcare infrastructure, making diagnostic services more accessible.
The infectious disease testing segment is expected to grow at a significant CAGR over the forecast period. Vacuum blood collection tubes are crucial in diagnosing viral infections such as HIV, hepatitis, tuberculosis, and COVID-19. The rising concern about infection control and the demand for early detection globally are driving the need for these diagnostic methods, especially in high-risk areas. As governments and health institutions invest in improving diagnostic capacity and lab networks, particularly in low and middle-income economies, the use of these tubes in infectious disease testing is expected to increase.
Why Did the Hospitals Segment Lead the Market?
The hospitals segment continues to dominate the vaccum blood collection tube market. Hospitals, serving as major care points, handle numerous patients daily and conduct many diagnostic analyses, including routine blood tests, emergency testing, and screenings. The high clinical standards in hospitals encourage the use of high-quality collection systems. As healthcare infrastructure improves globally and chronic and infectious diseases increase, hospitals are performing more routine and preventative analyses.
The diagnostic laboratories segment is expected to grow at the highest CAGR in the upcoming period. Diagnostic laboratories play a crucial role in disease diagnosis, treatment monitoring, and health screening. As lab tasks vary, from simple hematology to complex genetic diagnostics, the need for specialized collection tubes increases. Accuracy and efficiency are priorities in diagnostic labs, making vacuum tubes essential because they fit into automated systems and preserve sample integrity. The increased patient footfall in these laboratories further contributes to segmental growth. The growth of private lab chains, the demand for healthcare prevention education, and the rise in home collection services ensure the long-term growth of the segment.
What Made Direct Tender the Dominant Segment in the Market in 2024?
The direct tender segment captured a revenue share of 46% in 2024. This is mainly due to the increased need for immediate delivery of products. Direct tenders ensure timely procurement, reduce administrative costs, and enable cost-effective bulk purchases at negotiated rates. Healthcare providers, especially in centralized healthcare regions, find the efficiency of direct tenders appealing. This procurement system remains a primary mode for the mass supply and distribution of vacuum blood collection tubes.
The online sales segment is expected to grow at a significant CAGR over the forecast period. The increasing digitalization of purchase activities, along with the ease of use on e-commerce websites, attracts healthcare facilities, diagnostic labs, and practitioners to online purchasing of vacuum blood collection tubes. Online platforms improve accessibility to a wide range of products. These platforms offer competitive pricing and doorstep delivery services, encouraging reapeat purchases. Manufacturers are also focusing on expanding their online presence to reach buyers directly and offer tailored products, supporting segmental growth.
(Source: https://www.captodayonline.com)
(Source: https://www.bd.com)
(Source: https://www.cangzhoufukang.com)
By Product Type
By Material
By Application
By End User
By Distribution Channel
By Region
For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
April 2025
May 2025
August 2024
June 2025